PDE10A Knockout HAP1 Cell Line

The choice depends on whether you are studying PDE10A's role as a dual cAMP/cGMP phosphodiesterase or modeling its functions in striatal signaling and schizophrenia drug development. The Knockout line is the standard tool for asking whether PDE10A is required for cyclic nucleotide hydrolysis — PDE10A is principally expressed in striatal medium spiny neurons where it regulates cAMP/cGMP levels and downstream PKA/PKG signaling. Overexpression is useful for studying PDE10A in heterologous expression contexts. Important consideration: PDE10A is principally expressed in striatal neurons — HAP1 is not the physiological context for PDE10A function. The EDITGENE Knockout in HAP1 is most useful for in vitro biochemistry and as a clean background for PDE10A inhibitor testing. PDE10A is a validated psychiatric drug target — PDE10A inhibitors (TAK-063/balipodect, MP-10/PF-02545920, LU AF11167) have been investigated for schizophrenia, although clinical efficacy has been limited. Rescue with wild-type or catalytically-dead PDE10A is the standard specificity control.

Primary applications: • Dual cAMP/cGMP hydrolysis: cellular cAMP and cGMP measurement following adenylyl cyclase or guanylyl cyclase activation to characterize PDE10A's dual specificity. • PDE10A inhibitor specificity: critical genetic control for TAK-063 (balipodect), MP-10 (PF-02545920), and other PDE10A-targeting compounds in schizophrenia and Huntington's disease drug development. • Striatal signaling biology: in heterologous neuronal contexts, characterization of PDE10A's striatal medium spiny neuron functions. • PKA/PKG signaling: downstream cAMP/cGMP effector pathway analysis. EDITGENE recommends this model for in vitro PDE10A biochemistry and inhibitor specificity testing. Physiological striatal PDE10A research requires neuronal models.

Yes. PDE10A rescue experiments require attention to dual-domain architecture: • Construct design: use a codon-modified PDE10A sequence with a small C-terminal tag (FLAG, HA). PDE10A has two N-terminal GAF domains (cGMP-binding regulatory) and C-terminal catalytic domain — preserve all elements. • Catalytically-dead rescue: catalytic domain residue mutations affecting Zn²⁺/Mg²⁺ coordination abolish cyclic nucleotide hydrolysis activity. • GAF domain mutant rescue: GAF-A or GAF-B domain mutations enable studies of allosteric regulation by cGMP. • Functional readout: rescue should restore cellular cAMP/cGMP hydrolysis activity. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.